Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease

Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease

Background Evidence‐based therapies are generally underused for cardiovascular risk reduction; however, less is known about contemporary patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. Methods and Results Pharmacy and medical claims data from within Anthem were que...

Full description

Bibliographic Details
Main Authors: Adam J. Nelson, Maddalena Ardissino, Kevin Haynes, Sonali Shambhu, Zubin J. Eapen, Darren K. McGuire, Anthony Carnicelli, Renato D. Lopes, Jennifer B. Green, Emily C. O’Brien, Neha J. Pagidipati, Christopher B. Granger
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atherosclerotic cardiovascular disease
diabetes mellitus
evidence‐based
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.016835

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.016835

Similar Items